Reuters, December 4, 2017

Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients’ tumours and guide them to effective therapies.

Facebook icon
LinkedIn icon
Twitter icon